Douglas R.obbins Phd

Douglas Robbins PHD, a sole proprietorship based in Birmingham, Alabama, provides independent disability case review and regional medical consultant services to the Social Security Administration as a prime contractor under a portfolio of blanket purchase agreements and indefinite delivery vehicles. The vendor operates exclusively in the full-and-open competitive market with no set-aside designations; all 75 awards in the source data are prime contracts issued without socioeconomic set-asides.

Douglas Robbins PHD has worked solely with the Social Security Administration across recent years, representing 100% customer concentration and 77% of awards in the source data (58 awards, $4.1 million combined potential value). The work centers on independent medical case reviews supporting SSA's Southeastern Program Service Center Disability Processing Branch and regional hearing offices in the Birmingham, Alabama area. Representative contracts include a $281,550 firm fixed-price call order issued May 5, 2023 against BPA 28321321AC0440006 for 3,000 independent case reviews at the Birmingham hearing office, a $190,880 call order under the same BPA for 2,000 case reviews issued April 19, 2024, and a $155,296 BPA call effective July 1, 2026 through June 30, 2027 for medical consultant services supporting disability adjudication. The vendor's NAICS concentration reflects this focus: 46 awards fall under Offices of Physicians (except Mental Health Specialists), with 9 awards in Offices of Physicians, Mental Health Specialists, indicating the bulk of work involves psychological and psychiatric medical review expertise.

The vendor holds seats on multiple SSA IDVs and BPAs. The top parent vehicles by task-order volume are Indefinite Delivery Contract 6009854032 (15 task orders), BPA SS04164C029 (10 task orders, $1.3 million combined potential value), BPA 28321321AC0440006 (8 task orders, $1.3 million), and Indefinite Delivery Contracts 06000354021 and SS040860024 (7 and 6 task orders respectively, totaling $1.5 million combined potential value). Awards per year have remained flat to minimal — one award in 2022, one in 2023, two in 2024, two in 2025, and one in 2026 — indicating mature, stable delivery-order placement rather than growth trajectory. Only one award (combined potential value $155 thousand) faces ultimate completion inside the next twenty-four months, creating minimal recompete exposure. Combined obligated dollars ($6.2 million) exceed combined potential value by 7 percentage points, reflecting full utilization of agreed ceilings across the portfolio.